• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Isolation and mechanism study of cell cycle inhibitors from microbial metabolites.

Research Project

Project/Area Number 09460058
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Bioproduction chemistry/Bioorganic chemistry
Research InstitutionRIKEN

Principal Investigator

OSADA Hiroyuki  RIKEN Antibiotics Laboratory Chief Scientist, 抗生物質研究室, 主任研究員 (80160836)

Co-Investigator(Kenkyū-buntansha) USUI Takeo  RIKEN Antibiotics Laboratory Scientist, 抗生物質研究室, 研究員 (60281648)
UEKI Masashi  RIKEN Antibiotics Laboratory Scientist, 抗生物質研究室, 研究員 (90312264)
Project Period (FY) 1997 – 2000
KeywordsG1 phase / protein synthesis inhibition / cell cycle / Curvularia sp. / new compound / sesquiterpene / trichotecene
Research Abstract

We have been screening microbial metabolites of soil actinomycetes and fungi to obtain new cell cycle inhibitors. The cell cycle analysis was carried out by flow cytometry using tsFT210 cell, a temperature-sensitive mutant cell line of cdc2 kinase. During this screening, a new cell cycle inhibitor named curvularol was discovered from the fermentation broth of a fungus, Curvularia sp. 97-F166, isolated in Nagasaki Prefecture. Curvularol was purified by a successive column chromatography and obtained as a colorless needle crystal. Its molecular weight and molecular formula were determined to be 266 and C_<15>H_<22>O_4, respectively, according to high-resolution FAB mass spectrometry. The structure of curvularol was elucidated by the detailed analyses of its 1D and 2D NMR spectra. It is a new sesquiterpen structurally related to trichotecenes to some extent.
Curvularol showed a weak antimicrobial activity at the concentration of 100 μg/ml, but showed a strong cytotoxicity at the concentration range of 50〜500 ng/ml, in vitro. The effect of curvularol against the cellular macromolecular synthesis was examined, and the primary target of curvularol was suggested to be protein synthesis. It blocked the cell cycle progression at G1 phase of various cell lines including, tsFT210, src^<ts>-NRK at 50 ng/ml.

  • Research Products

    (52 results)

All Other

All Publications (52 results)

  • [Publications] S.Ganesh, et al: "Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dualspecifisity phosphatase associated with polyribosomes."Human Mol.Genet.. 9. 2251-2261 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Hamaguchi, et al: "Synthesis and characterijation of a potent and selective protein tyrosine phosphatase inhibitor, 2-[(4-methylthiopyridin-2-yl)methylsulfinyl] benzimidazole."Bioorg.Med.Chem.Lett.. 10. 2657-2660 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Matsumoto, et al: "Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappaB ligand (RANKL)."J.Biol.Chem.. 275. 31155-31161 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Matsumoto. et al: "Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor."FEBS Lett.. 486. 23-28 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] J.F.Sans-Cevera, et al: "Synthesis and evaluation of microtubule assembly inhibition and cytotoxic of prenylated derivatives of cyclo-L-Trp-L-Pro."Bioorg.Med.Chem.. 8. 2407-2415 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Simizu, et al: "Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-induced baby hamster kidney cells."Jpn.J.Cancer Res.. 91. 706-714 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Wang, et al: "Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogs."J.Med.Chem.. 43. 1577-1585 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Watabe, et al: "MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria."Cancer Res.. 60. 5214-5222 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Watabe, et al: "Activation of MST/Krs and c-Jun N-terminal kinases by different signaling pathways during cytotrienin A-induced apoptosis."J.Biol.Chem.. 275. 8766-8771 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Watanabe, et al: "Synthesis of pironetin and related analogs : Studies on structure-activity relationships as tubulin assembly inhibitors."J.Antibiot.. 53. 540-545 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.R.Ko, et al: "CRM646-A and -B, novel fungal metabolites that inhibit heparinase."J.Antibiot.. 53. 211-214 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Kawatani, et al: "Involvement of protein kinase C-regulated ceramide generation for inostamycin induced apoptosis"Exp.Cell Res.. 259. 389-397 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Simizu & H.Osada: "Mutations of Plk gene lead to instability of Plk protein in human cancer cell lines."Nature Cell Biol.. 2. 852-854 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Sudo, et al: "p62 functions as a p38 MAP kinase regulator."Biochem.Biophys.Res.Commun.. 269. 521-525 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Maruyama, et al: "Immunolocalization of p38 MAP kinase in mouse brain."Brain Res.. 887. 350-358 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Honda, et al: "Isolation, and biological properties of a new cell cycle inhibitor, Curvularol, isolated from Curvularia sp.RK97-F166."J.Antibiot.. 54. 10-16 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Togashi, et al: "CRM646-A and thielavin B inhibit telomerase activity."Biosci.Biotech.Biochem.. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Sodeoka, et al: "Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and Cdc25B inhibition."J.Med.Chem.. (in press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 渡部正彦 他: "Effect of microgravity on cell proliferation signal."日本マイクログラビティ応用学会誌. 17. 87-90 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 長田裕之 他: "進化する抗がん剤「第4回がん分子標的治療研究会」見聞録"化学と生物. 38. 799-803 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 長田裕之 他: "微小管機能に関与するタンパク質とその低分子阻害剤 Microtubule proteins and chemical inhibitors"バイオサイエンスとインダストリー. 58. 35-38 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 臼井健郎 & 長田裕之: "微小管に作用するアルカロイド化合物 新しい微小管作用薬開発のリード化合物としての可能性"化学と生物. 39. 79-81 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 鶴尾隆 他: "分子標的阻害に基づく癌治療"Cancer up to date. 3. 2-9 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.Osada, et al: "Bioprobes"Springer : Ed.H.Osada. 319 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 長田裕之(分担): "癌治療の新たな試み新編II「癌化学療法の新しい分子標的 DNA傷害と修復」"医薬ジャーナル社:西條長宏 編. 414 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 掛谷秀昭 & 長田裕之 (分担): "科学技術予測レポート「バイオプローブの開発動向と将来性」"日本能率協会. 531 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Ganesh, et al: "Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specifisity phosphatase associated with polyribosomes."Human Mol.Genet.. 9. 2251-2261 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Hamaguchi, et al: "Synthesis and characterijation of a potent and selective protein tyrosine phosphatase inhibitor, 2-[(4-methylthiopyridin-2-yl) methylsulfinyl] benzimidazole."Bioorg.Med.Chem.Lett.. 10. 2657-2660 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Matsumoto, et al: "Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappaB ligand (RANKL)."J.Biol.Chem.. 275. 31155-31161 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Matsumoto, et al: "Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor."FEBS Lett.. 486. 23-28 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] J.F.Sans-Cevera, et al: "Synthesis and evaluation of microtubule assembly inhibition and cytotoxic of prenylated derivatives of cyclo-L-Trp-L-Pro."Bioorg.Med.Chem.. 8. 2407-2415 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Simizum, et al: "Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-induced baby hamster kidney cells."Jpn.J.Cancer Res.. 91. 706-714 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Wang, et al: "Synthesis and evaluation of tryprostatin B and demethoxyfumitremorgin C analogs."J.Med.Chem.. 43. 1577-1585 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Watabe, et al: "MT-21 is a synthetic apoptosis inducer that directly induces cytochrome c release from mitochondria."Cancer Res.. 60. 5214-5222 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Watabe, et al: "Activation of MST/Krs and c-Jun N-terminal kinases by different signaling pathways during cytotrienin A-induced apoptosis."J.Biol.Chem.. 275. 8766-8771 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Watanabe, et al: "Synthesis of pironetin and related analogs : Studies on structure-activity relationships as tubulin assembly inhibitors."J.Antibiot.. 53. 540-545 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.R.Ko, et al: "CRM646-A and-B, novel fungal metabolites that inhibit heparinase."J.Antibiot.. 53. 211-214 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Kawatani, et al: "Involvement of protein kinase C-regulated ceramide generation for inostamy cin induced apoptosis"Exp.Cell Res.. 259. 389-397 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Simizu & H.Osada: "Mutations of Plk gene lead to instability of Plk protein in human cancer cell lines."Nature Cell Biol.. 2. 852-854 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Sudo, et al: "p62 functions as a p38 MAP kinase regulator."Biochem.Biophys.Res.Commun.. 269. 521-525 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Maruyama, et al: "Immunolocalization of p38 MAP kinase in mouse brain."Brain Res.. 887. 350-358 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Honda, et al: "Isolation, and biological properties of a new cell cycle inhibitor, Curvularol, isolated from Curvularia sp. RK97-F166."J.Antibiot.. 54. 10-16 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Togashi, et al: "CRM646-A and thielavin B inhibit telomerase activity."Biosci.Biotech.Biochem.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Sodeoka, et al: "Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and Cdc25B inhibition."J.Med.Chem.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Watabe, et al: "Effect of microgravity on cell proliferation signal."J.Jpn.Soci.Microgr.Appl.. 17. 87-90 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Osada, et al: "New antitumor agents."Kagaku to Seibutsu. 38. 799-803 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Osada, et al: "Microtubule proteins and chemical inhibitors."Bioscience & Industry. 58. 35-38 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Usui & Osada: "Alkaloids which effect on microtubule. Possibilities as a lead Compound for new anti-microtubule agents."Kagaku to Seibutsu. 39. 79-81 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Tsuruo, et al: "Cancer chemotherapy based on molecular-target inhibition."Cancer up to date. 3. 2-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Osada, et al: "Bioprobes"Springer : Ed.H.Osada. 319 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Osada, et al: "New target for cancer chemothrapy 「DNA damage and repair systems.」"Iyaku Journal : Ed.N.Saijo. 414 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Kakeya & H.Osada: "Gijutsu Yosoku Report 「Perspective of bioprobe development.」"Japan Management Association. 531 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi